Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Soleno Therapeutics Inc

SLNO
Current price
73.26 USD -0.97 USD (-1.31%)
Last closed 72.27 USD
ISIN US8342032005
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 704 693 248 USD
Yield for 12 month +60.90 %
1Y
3Y
5Y
10Y
15Y
SLNO
21.11.2021 - 28.11.2021

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California. Address: 100 Marine Parkway, Redwood City, CA, United States, 94065

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

108.63 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-1 958 000 USD

Current Quarter

Last Quarter

Key Figures SLNO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -182 442 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -45.06 %
PEG Ratio
Return On Equity TTM -87.35 %
Wall Street Target Price 108.63 USD
Revenue TTM
Book Value 5.36 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -4.38 USD
Diluted Eps TTM -4.38 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SLNO

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History SLNO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:15
Payout Ratio TTM
Last Split Date 26.08.2022

Stock Valuation SLNO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.023
Price Book MRQ 15.11

Financials SLNO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SLNO

For 52 weeks

36.93 USD 74.50 USD
50 Day MA 56.07 USD
Shares Short Prior Month 4 987 722
200 Day MA 51.32 USD
Short Ratio 2.52
Shares Short 4 660 601
Short Percent 15.05 %